Definition of mild to moderate ulcerative colitis in clinical trials: A systematic literature review - Université de Lorraine Access content directly
Journal Articles United European Gastroenterology Journal Year : 2022

Definition of mild to moderate ulcerative colitis in clinical trials: A systematic literature review

Abstract

We performed a systematic review to investigate the definition of mild to moderate active ulcerative colitis (UC), and to describe predictors of good response to treatment in clinical trials assessing 5-ASA and/or budesonide. Thirty-nine randomized controlled trials were included. The UC Disease Activity Index (UCDAI) was the most frequent score used for defining mild to moderate active UC (16 studies, 41%), followed by Clinical Activity Index in 11 studies (28.2%). Four different cut-offs were used to define mild to moderate active UC using the UCDAI. The most frequently reported predictors of good response to treatment was a mild and moderate disease activity. There is heterogeneity in the definition of mild to moderate active UC in randomized clinical trials. A standardized definition of mild to moderate active UC used for inclusion of patients in clinical trials is needed.

Dates and versions

hal-04167999 , version 1 (21-07-2023)

Identifiers

Cite

Bénédicte Caron, Vipul Jairath, Ferdinando D’amico, Kristine Paridaens, Fernando Magro, et al.. Definition of mild to moderate ulcerative colitis in clinical trials: A systematic literature review. United European Gastroenterology Journal, 2022, 10 (8), pp.854-867. ⟨10.1002/ueg2.12283⟩. ⟨hal-04167999⟩
9 View
0 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More